Atrial fibrillation Trials in Nijmegen, Netherlands
Conditions / Atrial fibrillation / Nijmegen, Netherlands
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02866175 | Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT00224757 | Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study | COMPLETED | NA |
| NCT00580216 | Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation | TERMINATED | PHASE3 |
| NCT04342832 | Cryoballoon Ablation Versus Medical Therapy in Patients With Heart Failure and Atrial Fibrillation | TERMINATED | NA |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02348723 | Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) | COMPLETED | PHASE4 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT02944019 | Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation | COMPLETED | — |
| NCT02164864 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | COMPLETED | PHASE3 |